KNSL Gains 19.6% in Three Months: What Investors Should Know?

Shares of Kinsale Capital Group, Inc. (KNSL) have gained 19.6% in the past three months compared with the industry’s 4.2% growth.

KNSL shares have benefited from strong earnings, robust underwriting performance and high returns. The insurer has surpassed earnings estimates in each of the last four quarters, with the average being 8.9%. However, its premium valuation and continued weakness in commercial property pricing could limit further upside, while slower premium growth may weigh on future earnings.

Shares of other industry players like American Financial Group, Inc. AFG, Arch Capital Group Ltd. ACGL and CNA Financial Corporation CNA have gained 6.3%, 2.2% and 13.3%, respectively, over the past three months.

3-Month Price Performance: KNSL, CNA, AFG, ACGL & Industry

Image Source: Zacks Investment Research

KNSL’s Growth Projection Encourages

The Zacks Consensus Estimate for Kinsale Capital’s 2026 earnings per share (EPS) indicates a year-over-year increase of 8.2%. The consensus estimate for revenues is pegged at $1.92 billion, implying a year-over-year improvement of 5.5%.

Image Source: Zacks Investment Research

The consensus estimate for 2027 EPS and revenues indicates an increase of 1.9% and 0.9%, respectively, from the corresponding 2026 estimates.

Earnings have grown 38% in the past five years, better than the industry average of 22.7%. The expected long-term earnings growth rate is 15%, outperforming the industry average of 7.5%.

KNSL’s Efficient Use of Shareholder Funds

Kinsale Capital’s return on equity (ROE) was 25.8% for the trailing 12 months, better than the industry’s 7.4%, reflecting the company’s efficiency in utilizing shareholders’ funds. This insurer targets mid-teens ROE over the long term.

What’s Driving KNSL Stock

Kinsale Capital prioritizes profitability over premium growth and avoids poorly priced business, helping protect margins in a soft E&S market. In the second quarter of 2026, underwriting income rose 10.5% to $105.4 million, while net earned premiums increased 8.9%. Its 75.5% combined ratio and 24.4% ROE in the second quarter of 2026 highlight strong underwriting performance. Management targets a long-term combined ratio in the mid-80% range.

Kinsale Capital continues to witness healthy growth outside commercial property, with Gross written premium (GWP) rising 3.7% in the second quarter and 4.8% in the first half of 2026. New business submissions increased 6%, while submissions excluding commercial property rose 8%. Strong demand in the small- and medium-sized enterprise market and favorable growth in excess casualty, commercial auto, entertainment, environmental, agribusiness casualty and energy support premium growth.

The company launched nine new products or enhancements in the first half of 2026, with five more set to launch soon and 10 in the pipeline. It also added 24 wholesale brokers and 176 retail brokers to Aspera, expanding market reach and supporting future premium growth.

KNSL is well-positioned to generate an improved expense ratio, given its proprietary technology platform, which includes 17 years of internal data, advanced analytics and machine learning to improve risk selection and pricing. This supports strong loss ratios even in a competitive market.

KNSL’s net investment income increased 19.9% year over year in the second quarter of 2026, supported by growth in the investment portfolio. The investment portfolio generated a 4.5% annualized gross return in the first half of 2026, while new-money yields were around 5.25%. As of June 30, 2026, Kinsale Capital's float increased to $3.4 billion from $3.1 billion at year-end 2025, providing a larger base for investment income.

Kinsale Capital’s operating cash flow supports organic growth, investment portfolio expansion and capital returns. Net cash provided by operating activities was $490.8 million in the first half of 2026 compared with $498.9 million a year earlier. The company repurchased $100 million of shares in the second quarter. In July 2026, the board added $250 million to the authorization, bringing remaining capacity to $337.5 million, providing additional support to EPS and shareholder returns.

Risks for KNSL

Intense competition in commercial property and casualty lines is pressuring pricing and growth. Commercial property GWP fell 32.7% in the second quarter of 2026, while overall pricing declined 5.9%. Kinsale Capital’s disciplined underwriting protects margins but may limit premium growth. Rising casualty loss costs and a shift toward longer-tail business could also pressure profitability.

Higher reinsurance retentions are raising KNSL’s expense ratio, while investment volatility has widened accumulated other comprehensive loss. Additionally, Kinsale Capital’s 4.17X price-to-book multiple, well above the P&C industry’s 1.41X, leaves limited room for execution missteps amid slower growth.

End Notes

Kinsale Capital is poised to gain from its long-term expansion in the United States. E&S market and its focus on smaller, hard-to-place risks, prudent underwriting, lower expense ratio, technology-enabled efficiency, higher investment income and effective capital deployment. Favorable growth estimates and higher return on equity are other positives.

However, given its slower commercial property growth and expensive valuation, it is better to wait for some more time before taking a call on this Zacks Rank #3 (Hold) stock. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research